| Literature DB >> 32367221 |
Filippo Migliorini1, Jörg Eschweiler2, Yasser El Mansy2,3, Valentin Quack2, Markus Tingart2, Arne Driessen2.
Abstract
BACKGROUND: The purpose of the current study was to clarify the role of the quadriceps tendon (QT) autograft for primary ACL reconstruction. Thus, a Bayesian network meta-analysis comparing patients undergoing a primary ACL reconstruction with QT versus patellar tendon (PT) and hamstring tendon (HT) autografts was conducted.Entities:
Keywords: ACL reconstruction; Autograft; Hamstring; Patellar; Quadriceps
Year: 2020 PMID: 32367221 PMCID: PMC8215032 DOI: 10.1007/s00590-020-02680-9
Source DB: PubMed Journal: Eur J Orthop Surg Traumatol ISSN: 1633-8065
Fig. 1Flow chart of the literature search
Fig. 2Risk of bias summary
Characteristics of the included studies and demographic data
| Author, year | Type of study | Procedures | Follow-up (months) | Type of autograft | Procedures | Mean age | Type of autograft | Procedures | Mean age |
|---|---|---|---|---|---|---|---|---|---|
| Aglietti et al. 2004 [ | RCT | 120 | 24.0 | PT | 60 | 25.0 | HT | 60 | 25.0 |
| Akoto et al. 2019 [ | RCS | 82 | 12.0 | QT | 41 | 29.0 | HT | 41 | 28.0 |
| Barenius et al. 2010 [ | RCT | 153 | 100.0 | PT | 78 | 33.0 | HT | 75 | 35.0 |
| Cavaignac et al. 2017 [ | RCS | 86 | 43.2 | QT | 45 | 32.1 | HT | 41 | 30.1 |
| Drogset et al. 2010 [ | RCT | 115 | 24.0 | PT | 58 | 26.0 | HT | 57 | 27.0 |
| Feller et al. 2001 [ | RCT | 65 | 4.0 | PT | 31 | 26.0 | HT | 34 | 27.0 |
| Geib et al. 2009 [ | RCS | 220 | 56.8 | QT | 190 | 31.7 | PT | 30 | 25.0 |
| Gorschewsky et al. 2007 [ | RCS | 260 | 35.0 | QT | 124 | PT | 136 | ||
| Han et al. 2008 [ | RCS | 144 | 41.0 | QT | 72 | 27.8 | PT | 72 | 27.8 |
| Häner et al. 2016 [ | PCS | 51 | 24.0 | QT | 25 | 35.9 | HT | 26 | 35.8 |
| Hart et al. 2010 [ | PCS | 40 | 12.0 | QT | 20 | 27.0 | HT | 20 | 27.0 |
| Kim et al. 2009 [ | RCS | 48 | 26.0 | QT | 21 | 27.1 | PT | 27 | 30.2 |
| Kim et al. 2014 [ | RCS | 247 | 24.0 | QT | 89 | PT | 158 | ||
| 122 | 24.0 | QT | 53 | PT | 69 | ||||
| Lee et al. 2016 [ | RCS | 96 | 35.0 | QT | 48 | 31.1 | HT | 48 | 29.9 |
| Lund et al. 2014 [ | RCT | 51 | 24.0 | QT | 26 | 30.0 | PT | 25 | 31.0 |
| Maletis et al. 2007 [ | RCT | 99 | 24.0 | PT | 46 | 27.2 | HT | 53 | 27.7 |
| Martin et al. 2018 [ | RCT | 51 | 24.0 | QT | 26 | 18.7 | HT | 25 | 19.2 |
| Mohtadi et al. 2015 [ | RCT | 206 | 39.0 | PT | 102 | 28.7 | HT | 104 | 28.5 |
| Runer et al. 2018 [ | RCS | 80 | 24.0 | QT | 40 | 34.6 | HT | 40 | 34.6 |
| Sofu et al. 2013 [ | RCS | 44 | 38.0 | QT | 23 | 26.8 | HT | 21 | 28.6 |
| Taylor et al.2009 [ | RCT | 53 | 36.0 | PT | 24 | 21.7 | HT | 29 | 22.1 |
| Todor et al. 2019 [ | RCS | 72 | 34.2 | QT | 39 | 30.6 | HT | 33 | 28.6 |
| Wipfler et al. 2011 [ | RCT | 48 | 105.6 | PT | 26 | 40.0 | HT | 22 | 34.0 |
| Zaffagnini et al. 2006 [ | RCT | 50 | 60.0 | PT | 25 | 31.0 | HT | 25 | 31.0 |
RCS retrospective cohort study; PCS prospective cohort study; RCT randomized clinical trial
Fig. 3Overall network comparisons regarding the endpoint: scores
Fig. 4Overall network comparisons regarding the endpoint: laxity
Fig. 5Overall network comparisons regarding the endpoint: complications